Milestone Pharmaceuticals Inc.

Contributing Author

Recent Articles by Milestone Pharmaceuticals Inc.

Jul-11	Milestone Pharmaceuticals Announces Pricing of $52.5 Million Public Offering of Common Shares, Pre-Funded Warrants, Series A Common Warrants and Series B Common Warrants MIST -39.06% GlobeNewswire
Jul-11	Milestone Pharmaceuticals Announces Proposed Public Offering MIST -39.06% GlobeNewswire
Jul-11	Milestone Pharmaceuticals Announces FDA Acceptance of the Company's Response to the CRL for CARDAMYST (etripamil) Nasal Spray MIST -39.06% GlobeNewswire
Jun-16	Milestone Pharmaceuticals Submits Response to the FDA's CRL for CARDAMYST (etripamil) Nasal Spray for PSVT Following Type A Meeting MIST GlobeNewswire
May-28	Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference MIST GlobeNewswire
May-14	Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update MIST GlobeNewswire